N-(4-Aminobenzoyl)-β-alanine - 25% aqueous solution
CAS : 7377-08-4
Ref. 3D-FA34152
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 25g | Arrêté | ||
| 50g | Arrêté | ||
| 100g | Arrêté |
Informations sur le produit
Nom :
N-(4-Aminobenzoyl)-β-alanine - 25% aqueous solution
Synonymes :
- 3-(4-Aminobenzoylamino)-Propionic Acid
- 3-[(4-Aminobenzoyl)amino]propanoic acid
- 3-[(4-Aminophenyl)formamido]propanoic acid
- 3-{[(4-Aminophenyl)Carbonyl]Amino}Propanoate
- N-(4-Aminobenzoyl)-Alanine
- N-(4-Aminobenzoyl)-B-Alanine
- N-(4-Aminobenzoyl)-Ss-Alanine
- N-(4-Aminobenzoyl)-Á-Alanine
- N-(P-Aminobenzoyl)-Beta-Alanine
- Timtec-Bb Sbb000472
- Voir d'autres synonymes
- p-Amino-N-benzoyl-β-alanine
- β-Alanine, N-(4-aminobenzoyl)-
- β-Alanine, N-(p-aminobenzoyl)-
- N-(4-Aminobenzoyl)-Beta-Alanine
Description :
N-(4-Aminobenzoyl)-beta-alanine is a molecule that was identified in the 1960s and has been used extensively for research purposes. It is a prodrug that is converted to salicylic acid in vivo. The drug has been shown to scavenge reactive oxygen species, inhibit the enzyme catalase, and protect against oxidative damage. N-(4-Aminobenzoyl)-beta-alanine also provides protection against colitis by inhibiting peroxide production and preventing oxidative damage of colon cells. This drug is orally active and may have potential clinical applications for patients with catalase deficiency or peroxide-mediated diseases such as colitis.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
208.21 g/mol
Formule :
C10H12N2O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
